The impact of stage and histology on the long-term clinical course of 163,808 patients with breast carcinoma

Cancer
J W GamelB A Miller

Abstract

Stage and histologic type have a significant impact on the long term clinical course of breast carcinoma. Clinical course is governed by two components: likelihood of cure and medial tumor-related survival time among uncured patients. Estimates of these components can be derived only by using survival models that incorporate cured fraction as a specific parameter. The prognostic value of stage and histologic type was determined for 163,808 patients with breast carcinoma using the log normal and log logit cure-based survival models. Follow-up ranged from 1 month to 19 years and was obtained from the SEER Program. In approximate terms, ductal carcinoma was diagnosed in 70% of the patients, with estimate cured fractions of 2/3 and 1/3 for local and regional disease, respectively. Estimates of medial survival times for uncured patients were 10 and 5 years. Findings were similar for patients with tumor of miscellaneous histologic types. For patients with medullary carcinoma were 82% and 50%, with median survival times of 6 and 4 years. For patients with mucinous, lobular, and ductolobular carcinomas, parametric analysis gave inconsistent estimates of cured fraction, but findings suggested unusually long tumor-related survival times....Continue Reading

References

Mar 1, 1992·Seminars in Surgical Oncology·D E HensonE M Shambaugh
Jan 1, 1986·Breast Cancer Research and Treatment·J S Meyer
Jan 1, 1994·Breast Cancer Research and Treatment·P S HupperetsG H Blijham
Apr 1, 1994·Computers and Biomedical Research, an International Journal·J W Gamel, I W McLean

❮ Previous
Next ❯

Citations

Mar 23, 2007·Breast Cancer Research and Treatment·Isabelle SoerjomataramJan Willem W Coebergh
Jun 19, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J HuoberB Thürlimann
Jul 11, 2012·Neuroepidemiology·Nicolas R SmollOliver P Gautschi
Jan 27, 2016·International Journal of Surgery Case Reports·Lucie WrightTarannum Fasih
Aug 13, 2008·Expert Opinion on Therapeutic Targets·Kai-Keen ShiuJorge S Reis-Filho
May 9, 2012·Current Medical Research and Opinion·Noemi MuszbekPaul Ross
Feb 25, 2003·Cancer·John W GamelMichael J Edwards
Mar 3, 2007·International Journal of Cancer. Journal International Du Cancer·Marieke W J LouwmanJan Willem W Coebergh
Mar 23, 2007·The British Journal of Surgery·A T StearnsD B Kingsmore
Feb 27, 2001·The American Journal of Surgical Pathology·R E JimenezD W Visscher
Mar 27, 2001·Psycho-oncology·E C ClippH J Cohen
May 26, 1999·The Journal of Pathology·D Jones, C D Fletcher
Apr 23, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Brian D BadgwellGildy Babiera
Mar 8, 2018·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·R ClèriesÀ Izquierdo
Aug 6, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M K Singhal, V Raina
Oct 1, 2009·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Benjaporn ChaiwunSongphol Srisukho
Nov 17, 2009·Journal of Cancer Research and Clinical Oncology·J M Del CasarF J Vizoso
May 26, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L M WoodsM P Coleman
Nov 5, 1999·Medical Care·B N DoebbelingC F Lynch
Nov 1, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J HuoberB Thürlimann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.